Log In
Print this Print this

Agrylin, Xagrid, anagrelide

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionSmall molecule that reduces platelet count
Molecular Target Unknown
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationThrombocytopenia
Indication DetailsTreat essential thrombocytopenia
Regulatory Designation Japan - Standard Review (Treat essential thrombocytopenia)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today